P4 · Lab

AMILI

P4 Healthtech & Diagnostics

AMILI is Southeast Asia's leading precision gut microbiome company, founded in Singapore in 2019, and runs the region's only microbiome transplant bank. It offers clinical gut health testing, microbiome restoration therapy, AI-powered analytics for healthcare partners, and physician-guided probiotic programs, and holds the world's largest multi-ethnic Asian gut microbiome database. Backed by Vulcan Capital and East Ventures, it collaborates with NUS, NUH, and Monash University.

Back to the Atlas